These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14433619)

  • 1. [A neuroleptic with antidepressive effect, "taractan" (Ro 4-0403)].
    POELDINGER W
    Praxis; 1960 May; 49():468-72. PubMed ID: 14433619
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the pharmacology of "taractan", a neuroleptic with special peculiarity of action].
    PELLMONT B; STEINER FA; BESENDORF H; BAECHTOLD HP; LAEUPPI E
    Helv Physiol Pharmacol Acta; 1960; 18():241-58. PubMed ID: 14431500
    [No Abstract]   [Full Text] [Related]  

  • 3. [Introduction to the pharmacology of taractan, a neuroleptic with a special mechanism of action].
    PELLMONT B; STEINER FA; BESENDORF H; BAECHTOLD HP; LAEUPPI E
    Schweiz Med Wochenschr; 1960 May; 90():598-9. PubMed ID: 14431499
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experiences with Taractan, a neuroleptic of the thioxanthene series].
    JOB J
    Med Welt; 1962 Aug; 34():1779-81. PubMed ID: 14451890
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experiences with the neuroleptic Taractan in anesthesia and clinical practice].
    GRIMMEISEN H
    Munch Med Wochenschr; 1961 Oct; 103():1923-5. PubMed ID: 13901959
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the pharmacology of a new neuroleptic: the alpha-isomer of 2-chloro-9(3-dimethyl-aminopropylidene)-thioxanthene or taractan. Anesthetic. hypothermic, antipyretic action and atropinic effect].
    FROMMEL E; FLEURY C; BEGUIN M
    C R Seances Soc Biol Fil; 1960; 154():1401-3. PubMed ID: 24545621
    [No Abstract]   [Full Text] [Related]  

  • 7. [New neuroleptics (R-1625 or Haloperidol, MD-2028 or Halo-Anisone, Ro 4-0403 or Taractan, and LG-206 or Dominal) in different types of anesthesia without narcosis or anesthesia in the waking state. Indications in neurosurgical anesthesiology. Place of analgesia in neuroleptanalgesia].
    DELIGNE P
    Agressologie; 1961; 2():363-70. PubMed ID: 13885151
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experiences with the thioxanthene derivative Ro 4-0403 (taractan)].
    HOFFET H; CORNU F
    Schweiz Med Wochenschr; 1960 May; 90():602-7. PubMed ID: 14402381
    [No Abstract]   [Full Text] [Related]  

  • 9. [Psychotropic drugs in psychiatric therapy and results obtained with a recent psychopharmacological agent: Taractan - Ro 40403/20].
    ENDRIZZI G
    Rass Neuropsichiatr; 1961; 15():319-43. PubMed ID: 13890188
    [No Abstract]   [Full Text] [Related]  

  • 10. Double-blind study of chlorprothixene (Taractan) a panpsychotropic agent.
    KARN WN; MEAD BT; FISHMAN JJ
    J Obstet Gynaecol Br Emp; 1961; 1():72-9. PubMed ID: 13751530
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical observations of therapeutic effect of chlorprothixene (Taractan) in psychoses.
    REZNIKOFF L
    Am J Psychiatry; 1961 Oct; 118():348-50. PubMed ID: 14491745
    [No Abstract]   [Full Text] [Related]  

  • 12. Taractan (chlorprothixene) as a neuroleptic drug in clinical psychiatry.
    GROSS H; KALTENBAECK E
    Dis Nerv Syst; 1961 Sep; 22():502-7. PubMed ID: 13709010
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the effect of taractan in predominantly chronic institutionalized patients].
    STELTER E
    Ther Umsch; 1962 Jun; 19():249-52. PubMed ID: 13916797
    [No Abstract]   [Full Text] [Related]  

  • 14. [COMPARATIVE STUDIES ON THE EFFECT OF ANTIDEPRESSIVE AND NEUROLEPTIC DRUGS ON THE POWER OF CONCENTRATION].
    HARTUNG ML; BENTE D; SCHNEEWIND KA
    Arzneimittelforschung; 1964 Jun; 14():SUPPL:584-7. PubMed ID: 14253973
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the effect of a thioxanthene derivative ("Taractan") in brain injuries].
    SCHMITTKAMP HJ
    Ther Umsch; 1962 Apr; 19():1959-61. PubMed ID: 13908843
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical trials of chloroprothixene (taractan)].
    FEER H; FUCHS M; STRAESSLE M
    Schweiz Med Wochenschr; 1960 May; 90():600-2. PubMed ID: 13821890
    [No Abstract]   [Full Text] [Related]  

  • 17. [Taractan--Truxal--chlorprothixenum (INN)].
    LUND E
    Nord Med; 1961 Jul; 66():1063-5. PubMed ID: 13764269
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the problem of the use of chlorprothixen ("Taractan") in the psychiatric hospital].
    von BRAUCHITSCH ; BUKOWCZYK A
    Schweiz Arch Neurol Neurochir Psychiatr; 1962; 90():104-17. PubMed ID: 13872568
    [No Abstract]   [Full Text] [Related]  

  • 19. [Taractan in some psychiatric entities].
    NARROS MARTIN G; CARRANZA SANCHEZ LJ
    Rev Clin Esp; 1962 May; 85():261-70. PubMed ID: 14478407
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic results obtained with Taractan in depression].
    CAMPANINI T; DE RISIO C; VALLA S
    Riv Sper Freniatr Med Leg Alien Ment; 1961 Mar; 85():264-8. PubMed ID: 13875997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.